Richard S. Warzala - Mar 7, 2023 Form 4 Insider Report for ALLIED MOTION TECHNOLOGIES INC (AMOT)

Signature
/s/ Michael C. Donlon, Attorney-in-Fact for Richard S. Warzala
Stock symbol
AMOT
Transactions as of
Mar 7, 2023
Transactions value $
$1,943,624
Form type
4
Date filed
3/9/2023, 04:33 PM
Previous filing
Jan 23, 2023
Next filing
Apr 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMOT Common Stock Tax liability -$113K -2.61K -0.17% $43.16 1.5M Mar 7, 2023 Direct F1
transaction AMOT Common Stock Award $519K +12K +0.8% $43.16 1.51M Mar 7, 2023 Direct F2
transaction AMOT Common Stock Award $519K +12K +0.8% $43.16 1.52M Mar 7, 2023 Direct F3
transaction AMOT Common Stock Award $1.02M +23.6K +1.55% $43.16 1.55M Mar 7, 2023 Direct F4
holding AMOT Common Stock 25.1K Mar 7, 2023 By ESOP Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On the indicated date, the Reporting Person instructed the Company to withhold shares of common stock to cover tax withholding obligations upon the vesting of restricted stock as permitted under the applicable shareholder-approved stock incentive plan.
F2 Grant of time-based restricted shares pursuant to the Company's 2017 Omnibus Incentive Plan. These restricted shares vest one-third each on April 1, 2024, 2025 and 2026.
F3 Grant of performance-based restricted shares pursuant to the Company's 2017 Omnibus Incentive Plan. All or a portion of these restricted shares will vest over a three-year period upon the satisfaction of certain performance goals established by the Compensation Committee for the year ending December 31, 2023.
F4 Grant of restricted shares pursuant to the Company's 2017 Omnibus Incentive Plan upon the satisfaction of the performance goals previously established by the Compensation Committee in connection with the Company's Long-Term Incentive Plan. These restricted shares vest over a two-year period.